 Justin Searns
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteomyelitis | 10 | 2024 | 143 | 4.680 |
Why?
| | Arthritis, Infectious | 6 | 2022 | 72 | 2.800 |
Why?
| | Pyomyositis | 3 | 2022 | 15 | 1.430 |
Why?
| | Kingella kingae | 2 | 2022 | 12 | 1.290 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2025 | 248 | 0.920 |
Why?
| | Musculoskeletal Diseases | 2 | 2025 | 88 | 0.920 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2025 | 39 | 0.890 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2025 | 81 | 0.850 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2025 | 136 | 0.810 |
Why?
| | Esotropia | 1 | 2023 | 27 | 0.790 |
Why?
| | Critical Pathways | 1 | 2023 | 108 | 0.710 |
Why?
| | Acute Disease | 5 | 2025 | 1030 | 0.700 |
Why?
| | Musculoskeletal System | 1 | 2022 | 49 | 0.690 |
Why?
| | Bacteremia | 1 | 2024 | 221 | 0.690 |
Why?
| | Child | 18 | 2025 | 22633 | 0.670 |
Why?
| | Bone Diseases, Infectious | 1 | 2020 | 8 | 0.640 |
Why?
| | Staphylococcal Infections | 1 | 2025 | 388 | 0.640 |
Why?
| | Retrospective Studies | 13 | 2025 | 17066 | 0.630 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2019 | 25 | 0.600 |
Why?
| | Agammaglobulinemia | 1 | 2019 | 36 | 0.590 |
Why?
| | Neisseriaceae Infections | 1 | 2018 | 6 | 0.580 |
Why?
| | Meningitis, Bacterial | 1 | 2019 | 45 | 0.570 |
Why?
| | Venous Thromboembolism | 1 | 2023 | 324 | 0.560 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 129 | 0.550 |
Why?
| | Bacterial Infections | 1 | 2020 | 246 | 0.550 |
Why?
| | Length of Stay | 3 | 2020 | 1337 | 0.530 |
Why?
| | Drug Resistance, Bacterial | 1 | 2018 | 196 | 0.520 |
Why?
| | Referral and Consultation | 1 | 2023 | 851 | 0.500 |
Why?
| | Osteoarthritis | 1 | 2018 | 196 | 0.480 |
Why?
| | Infant | 5 | 2025 | 10034 | 0.350 |
Why?
| | Acute Kidney Injury | 1 | 2020 | 865 | 0.350 |
Why?
| | Humans | 21 | 2025 | 144759 | 0.330 |
Why?
| | Anti-Bacterial Agents | 5 | 2022 | 1907 | 0.310 |
Why?
| | Hospitalization | 3 | 2025 | 2433 | 0.300 |
Why?
| | Sensitivity and Specificity | 2 | 2025 | 1985 | 0.290 |
Why?
| | Hospitals, Pediatric | 3 | 2020 | 556 | 0.270 |
Why?
| | Databases, Factual | 2 | 2025 | 1486 | 0.270 |
Why?
| | Child, Preschool | 5 | 2025 | 11787 | 0.260 |
Why?
| | Critical Illness | 2 | 2023 | 891 | 0.220 |
Why?
| | Myositis | 1 | 2020 | 57 | 0.150 |
Why?
| | Infant, Newborn | 2 | 2023 | 6429 | 0.150 |
Why?
| | Drug Hypersensitivity | 1 | 2021 | 90 | 0.150 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2020 | 104 | 0.150 |
Why?
| | Consciousness Disorders | 1 | 2019 | 23 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2020 | 175 | 0.150 |
Why?
| | Adolescent | 3 | 2025 | 22428 | 0.150 |
Why?
| | Clindamycin | 1 | 2018 | 14 | 0.150 |
Why?
| | Methyltransferases | 1 | 2018 | 74 | 0.140 |
Why?
| | Patient Discharge | 1 | 2025 | 983 | 0.140 |
Why?
| | Male | 6 | 2025 | 72315 | 0.130 |
Why?
| | Drug Utilization Review | 1 | 2017 | 61 | 0.130 |
Why?
| | Risk Factors | 2 | 2023 | 10779 | 0.130 |
Why?
| | Biomedical Research | 1 | 2023 | 710 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2023 | 947 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2019 | 893 | 0.110 |
Why?
| | Algorithms | 1 | 2023 | 1837 | 0.110 |
Why?
| | Female | 5 | 2025 | 78271 | 0.110 |
Why?
| | Intensive Care Units | 1 | 2020 | 916 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2017 | 589 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3409 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2018 | 955 | 0.090 |
Why?
| | Kidney | 1 | 2020 | 1495 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3863 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2024 | 11679 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1560 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5868 | 0.070 |
Why?
| | Young Adult | 1 | 2020 | 14105 | 0.050 |
Why?
| | California | 1 | 2022 | 475 | 0.040 |
Why?
| | Penicillins | 1 | 2021 | 61 | 0.040 |
Why?
| | Abscess | 1 | 2017 | 75 | 0.030 |
Why?
| | Central Venous Catheters | 1 | 2017 | 52 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 187 | 0.030 |
Why?
| | Drug Utilization | 1 | 2017 | 166 | 0.030 |
Why?
| | Fever | 1 | 2017 | 311 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 4282 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2017 | 691 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1289 | 0.020 |
Why?
| | Biomarkers | 1 | 2023 | 4271 | 0.020 |
Why?
| | Patient Readmission | 1 | 2017 | 758 | 0.020 |
Why?
|
|
Searns's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|